Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNetcall Regulatory News (NET)

Share Price Information for Netcall (NET)

Share Price is delayed by 15 minutes
Get Live Data
125.50    0.00 (0.00%)
Bid:
123.00
Ask:
128.00
Spread: 5.00 (4.065%)
Market Cap: £214.10m
NET Live PriceLast checked at - London Stock Exchange

Intraday Netcall Share Chart

Trading Update

3 Aug 2015 07:00

RNS Number : 8002U
Netcall PLC
03 August 2015
 

Netcall plc

("Netcall" or the "Company")

Trading Update

 

Netcall plc (AIM: NET), a leading customer engagement software provider, is pleased to provide a trading update for the year ended 30 June 2015.

 

The Board anticipates a satisfactory outcome for the year and expects to report record turnover and adjusted EBITDA. It is also pleasing to report a rise in order inflow during the second half of the year which augurs well for the future.

 

Netcall has seen good demand for its Liberty Customer Engagement platform underpinned by continued cross and upselling. This included, in particular, the health market where one in three NHS Trusts have now licensed the Group's Appointment Management Cycle product. An increasing proportion of new orders are based on SaaS delivery models and the Board is therefore considering accelerating its investment in Netcall's SaaS capabilities to meet this growing demand.

 

The Group maintained a strong cash position and a debt free balance sheet. At 30 June 2015 the net cash balance had increased to £13.7m (2014: £11.4m).

 

Henrik Bang, CEO of Netcall commented: "We continued to perform well in the second half of the year underpinned by good cross and up-sales together with an increasing number of orders based on SaaS delivery models.

 

"During the year the sales pipeline continued to grow and the Group has invested further to enhance the Liberty product suite. The focus on expanding the SaaS delivery capabilities has been well received by customers and has resulted in orders for the latest version of Liberty. Together with our strong balance sheet and broad customer base the Board believes Netcall is well positioned for the future."

 

For further enquiries, please contact:

 

Netcall plc

Tel. +44 (0) 330 333 6100

Henrik Bang, CEO

Michael Jackson, Chairman

James Ormondroyd, Group Finance Director

 

finnCap Limited (Nominated Adviser and Broker)

 

Tel. +44 (0) 20 7220 0500

Stuart Andrews / James Thompson Corporate Finance

Simon Johnson, Corporate Broking

 

About Netcall plc

 

Netcall is a UK company quoted on the AIM market of the London Stock Exchange. Netcall's software product suite provides compelling business process solutions for end-to-end customer engagement, incorporating multi-channel contact centre, workforce optimisation, business process management and enterprise content management. The Netcall software platform helps organisations meet the growing demands of their customers and prospects whilst improving internal efficiencies, thereby increasing profitability and customer satisfaction.

 

Netcall's customer base contains over 700 organisations in both the private and public sectors. These include two thirds of NHS Acute Health Trusts, major telecoms operators such as BT and leading organisations including Interflora, Lloyds Banking Group, Cineworld, Interserve, Prudential, British Sugar and Thames Water.

 

For further information, please consult the Netcall website: www.netcall.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQFLFXEDFLBBL
Date   Source Headline
15th Feb 20217:00 amRNSNew Liberty Platform releases
1st Feb 20217:00 amRNSTrading Update and Notice of Results
22nd Dec 20209:00 amRNSExercise of Options and Total Voting Rights
17th Dec 20201:51 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Statement
10th Dec 20208:50 amRNSChange of Registered Office
23rd Nov 20203:30 pmRNSHolding(s) in Company
23rd Nov 202010:42 amRNSExercise of Options and Total Voting Rights
20th Nov 20207:00 amRNSNotice of AGM and Posting of Annual Report
19th Nov 20203:55 pmRNSExtension of Long Term Incentive Plan
2nd Nov 20204:13 pmRNSCorrection: Exercise of Options and TVR
2nd Nov 202011:00 amRNSExercise of Options and Total Voting Rights
13th Oct 20207:01 amRNSAcquisition of RPA technology provider
13th Oct 20207:00 amRNSFinal Results
7th Oct 202012:45 pmRNSHolding(s) in Company
5th Oct 20207:00 amRNSNotice of Results
23rd Sep 20207:00 amRNSChange of Adviser
18th Sep 20209:23 amRNSHolding(s) in Company
23rd Jul 202011:00 amRNSDirector/PDMR Shareholding
14th Jul 20207:00 amRNSTrading Update
10th Jun 20205:51 pmRNSDirector/PDMR Dealing & Total Voting Rights
16th Apr 20202:57 pmRNSHolding(s) in Company
6th Apr 20202:18 pmRNSDirector/PDMR Shareholding
2nd Apr 20204:26 pmRNSDirector/PDMR Shareholding
4th Mar 20209:10 amRNSHolding(s) in Company
27th Feb 20207:00 amRNSHalf-year Report
5th Feb 20209:04 amRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update and Notice of Results
23rd Dec 201911:08 amRNSDirector/PDMR Shareholding
16th Dec 20197:00 amRNSLaunch of Liberty Create Test Studio
29th Nov 20197:00 amRNSDirector Dealing
28th Nov 20193:48 pmRNSHolding(s) in Company
25th Nov 20193:43 pmRNSExercise of Options and Total Voting Rights
21st Nov 20193:04 pmRNSResult of AGM
21st Nov 20197:00 amRNSAGM Statement
18th Nov 20197:00 amRNSNew Non-Executive Director
4th Nov 20194:20 pmEQSForm 8.3 - Netcall Plc
25th Oct 201912:41 pmRNSNotice of AGM
2nd Oct 20197:00 amRNSIssue of Shares
25th Sep 20197:00 amRNSFinal Results
24th Jul 20197:00 amRNSTrading Update and Notice of Results
29th May 20197:00 amRNSTrading Update
20th May 201911:32 amRNSDirector Dealing
7th May 20192:56 pmRNSExercise of Options and Total Voting Rights
22nd Mar 20193:48 pmRNSDirector/PDMR Shareholding
11th Mar 20198:56 amRNSExercise of Options and Total Voting Rights
5th Mar 20195:54 pmRNSPDMR Dealing
5th Mar 201910:49 amRNSDirectors' Dealing
5th Mar 20197:00 amRNSHalf-year Report
29th Jan 20197:00 amRNSTrading Update and Notice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.